n
 
About Us       Blog       Clients       Disclaimer       Market Basics       Partners       Quotes & News       Video       Contact Us
The QualityStocks Daily Newsletter for Friday, May 19th, 2017

The QualityStocks
Daily Stock List

graphic
graphic

NuLife Sciences, Inc. (NULF)

MarketWatch and Investors Hub reported on NuLife Sciences, Inc. (NULF), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Established in 2013, NuLife Sciences, Inc. concentrates on advancing human organ transplant technology and medical research.  A biomedical company, it has a patent protected unique proprietary method (the NuLife Technique). The Company focuses on medical research and technology that has the potential to address significant unmet medical needs in applications including transplantation/regenerative medicine/cell therapy/organ and tissue transplants. NuLife Sciences has its headquarters in San Clemente, California.

The Company formerly went by the name SmooFi, Inc. It changed its corporate name to NuLife Sciences, Inc. in December 2016. NuLife Sciences’ shares trade on the OTC Markets Group’s OTCQB. The Company’s wholly-owned subsidiary is NuLife BioMed.

Mr. John Hollister, Chief Executive Officer of NuLife Sciences, said in December 2016, "We are moving forward as NuLife Sciences, a name that better reflects our focus on a unique patented proprietary method, the 'NuLife Technique', that could potentially eliminate the need for an organ or tissue match and the necessity for anti-rejection drugs in human organ transplant."

Mr. Hollister further said, “With the Discovery phase completed, we now intend to enter a Preclinical phase involving animal experiments in collaboration with Florida International University and Nova Southeastern University.”

The Company’s technique is versatile and is suitable for an assortment of clinical indications. At present, NuLife Sciences is entering a Preclinical phase involving animal experiments on its road to commercialization. Furthermore, NuLife provides an online marketplace and community. This is to assist in creating jobs, and to enable entrepreneurs and service providers to offer health related products and services.

The NuLife Technique was developed through 15 years of dedicated research. The result has been numerous breakthroughs in hematopoietic research and transplant techniques. The aim of the research was to address the issues of organ compatibility and the need for anti-rejection drugs in the donor. NuLife Sciences has comprehensive patent and Intellectual Property (IP) protections in place.

NuLife Sciences, Inc. (NULF), closed Friday's trading session at $0.64, up 9.44%, on 312 volume with 1 trade. The average volume for the last 60 days is 3,889 and the stock's 52-week low/high is $0.1012/$1.50.

Kiwa Bio-Tech Products Group Corp. (KWBT)

Equities, SmallCapVoice, Wallstreetlivechat, Lions of Wall Street, Fast Moving Stocks, Darth Trader, The Stock Psycho, Top Gun, Penny Stock Rumble, StockMister, The Penny Play, and OTC Picks reported on Kiwa Bio-Tech Products Group Corp. (KWBT), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Kiwa Bio-Tech Products Group Corporation is a manufacturer focused on eco-friendly bio-based fertilizers promoting soil health. The Company develops, manufactures, distributes, and markets novel, cost-effective and environmentally safe bio-technological products for agricultural and environmental conservation. OTCQB-listed, Kiwa Bio-Tech Products Group has its corporate office in Claremont, California.

The Company’s commitment is to making safe food, further developing eco-agriculture, and upholding a responsibility of contributing to China's agricultural safety, food safety, and a healthy lifestyle. Its dedication is to eco-agricultural development and environmental control through developing, producing, and selling bio-technological products with high technology, low-cost, and high productivity to satisfy increasing market demand.

The design of Kiwa Bio-Tech’s products is to enhance the quality of human life through increasing the value, quality, and productivity of crops and lessening the negative environmental impact of chemicals and other wastes. The Company uses new bio-technological skills at its core. Organic, ecologically sound, and "green" practices are its theme.

In March of this year, Kiwa Bio-Tech announced that it signed a strategic cooperation agreement with the Beijing Zhongpin Agricultural Science and Technology Development Center (Zhongpin Center). Zhongpin Center is the Chinese Agricultural Science and Technology Innovation and Development Committee's executive implementation agency (called the Agricultural Science and Technology Commission).

Via the guidance and support by the Zhongpin Center, Kiwa Bio-Tech will participate and be involved in China's National Soil Remediation Program and construction of the National Ecological Security Agriculture Industrial Chain Standardization System's operation and process.

Recently, Kiwa Bio-Tech Products Group announced that it signed a cooperation/distribution agreement with Yantai Fruit Company in Yantai City, Shandong Province, China. With this agreement, the parties will set up cooperative establishments in Yantai, Weihai, Weifang, and Qingdao, and the other areas to be mutually agreed, to manufacture and sell bio-organic fertilizer, compound microbial fertilizer and other products using Kiwa Bio-Tech's technical support and fertilizer products in the growth of fruit in the region. Simultaneously, the Company will work to build a new brand of biologically safe fruit to undergo marketing via the network the parties develop.

Kiwa Bio-Tech Products Group Corp. (KWBT), closed Friday's trading session at $2.45, up 2.08%, on 4,200 volume with 2 trades. The average volume for the last 60 days is 2,023 and the stock's 52-week low/high is $0.621/$3.00.

IDM Mining Ltd. (IDMMF)

Stockhouse, MarketWatch, Investors Hub and Bloomberg reported on IDM Mining Ltd. (IDMMF), and today we are reporting on the Company, here at the QualityStocks Daily Newsletter.

IDM Mining Ltd. is a mineral exploration and development company listed on the OTC Markets Group’s OTCQB. It focuses on low capital expenditure high-grade precious metal asset development. The Company’s present exploration and development activities center on precious metals in British Columbia (BC). The Company’s chief emphasis is on the high-grade, underground Red Mountain Gold Project. IDM Mining is based in Vancouver, British Columbia.

The Red Mountain Gold Project is advancing through the BC and Canadian environmental assessment processes with complete, thorough, and continuing consultation with Nisga'a Nation. This Project is situated 15 kilometers east of Stewart, BC, and is 17,125 hectares.

IDM Mining is advancing a Feasibility Study for a high-grade, underground gold mine. It envisions primarily bulk underground mining methods and the production of gold doré on site.

Recently, IDM Mining announced the appointment of Mr. Ryan Weymark, P. Eng, PMP as Project Director, effective May 1, 2017, for the Red Mountain Underground Gold Project. Mr. Weymark joins IDM Mining from Ledcor Contractors Ltd., where he was most recently a Project Manager responsible for leading and reviewing estimates, contract and subcontract negotiations, First Nation engagement, and managing operational projects in the mining and telecommunications sectors.

In his new role, Mr. Weymark will manage the transition of the project from the Feasibility Study that is now nearing completion, to final design, detailed engineering and preparing the project for potential construction and operations. The work will include ensuring alignment with the overall project schedule, contract management, cost control, supporting project permitting and health, safety and environmental management.

IDM Mining’s principal goal is to be positioned to make a construction decision at Red Mountain during this calendar year. Red Mountain hosts a well-drilled, high-grade resource, accessed by a production-sized underground decline.

The deposit (at an average potential mining width of 16 meters) is amenable to low-cost bulk mining techniques such as longhole stoping.  Moreover, the Property has excellent exploration potential for more discoveries along a 12-kilometer trend of many prospects and favorable geology. 

IDM Mining Ltd. (IDMMF), closed Friday's trading session at $0.1092, up 0.46%, on 33,200 volume with 8 trades. The average volume for the last 60 days is 56,274 and the stock's 52-week low/high is $0.082/$0.2054.

Worlds, Inc. (WDDD)

TopPennyStockMovers and Barchart reported earlier on Worlds, Inc. (WDDD), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Worlds, Inc. is a top intellectual property (IP) developer and licensee of patents related to 3D online virtual worlds. The Company has a portfolio of 10 U.S. patents for multi-server technology for 3D applications. Worlds has developed patented 3D technology that provides 3D multi-user environments, called "virtual worlds." The Company developed software and related technology for the creation of 3D Internet environments covering massively multiplayer online role-playing games (MMORPG). Worlds is based in Brookline, Massachusetts.

The design of Worlds’ 3D Internet sites are to enable visitation by users through providing them with online communities featuring different content and interactive capabilities. The Company’s technology is utilized in diverse applications. These include virtual meeting places, 3D e-commerce stores, as well as virtual classrooms

The Company designs and develops software, content, and related technology for the creation of interactive 3D Internet Websites. Worlds’ plan is to monetize its patent portfolio by way of enforcement, licensing, and royalties of its patented technologies.

The design of its technologies is for large-scale communities of simultaneous online users, who interact within online interactive 3D virtual worlds. These 3D communities allow visitors to interact with each other, teleport throughout the Worlds environment, and participate in shared experiences.

The virtual worlds have interactive Avatars, rich media graphics, text chat, voice-to-voice chat, video, and e-commerce. Worlds partners with existing content providers that have strong brands and an existing following. Also, the Company encourages individuals to create their own virtual spaces, communities, and unique Avatars with user-friendly tools.

In December 2016, Worlds announced that the U.S. Patent & Trademark Office (USPTO) validated six patent claims by Worlds following Patent Trial and Appeal Board (PTAB) review of World's influential technology. This technology has been central to the development of massively multiplayer online role-playing gaming (MMORPG) into a $20-billion-dollar industry. Validated claims were: Claims 4, 8, 13, and 16 of Patent 7,181,690 B1 - IPR2015-01268, and claims 5 and 7 of Patent 7,493,558 B2 - IPR2015-01269.

The “Worlds Player” enables shared state for mesh objects. Shared state permits other users to see dynamic changes to objects, which have this property activated. Therefore, for example, when a ball is ‘kicked’ all users present will see this action. This feature creates an opportunity for enhanced social interaction and game play. Furthermore, “Inventory” permits users to trade items or be awarded items. It also provides the basis for the installation of an ‘in Worlds’ currency. Currency and tradable items will make innovative features available to Worlds Members, including special/hidden rooms, videos and music.

Worlds, Inc. (WDDD), closed Friday's trading session at $0.02255, up 7.38%, on 18,500 volume with 3 trades. The average volume for the last 60 days is 169,676 and the stock's 52-week low/high is $0.0075/$0.0649.

Arch Therapeutics, Inc. (ARTH)

Equity Observer, PCG Advisory, Stock Beast, Value Penny Stocks, PennyPro, Wall Street Mover, Penny Stock General, Shiznit Stocks, Stock Commander, Fast Money Alerts, HotStockProfits, Jet-Life Penny Stocks, Stock Shock and Awe, Promotion Stock Secrets, Stock Gumshoe, and Wall Street Resources reported earlier on Arch Therapeutics, Inc. (ARTH), and we highlight the Company as well, here at the QualityStocks Daily Newsletter.

A medical device company, Arch Therapeutics, Inc. is a developer of novel liquid, gel and solid hemostatic and wound care devices. It is developing a novel approach to stop bleeding (hemostasis) and control leaking (sealant) during surgery and trauma care. Its goal is to develop and commercialize products based on its pioneering technology platform. This platform makes surgery and interventional care faster and safer for patients. The underlying technology, exclusively licensed from a leading university, supports an inventive platform of smart materials that fulfill the criteria as a solution for a specialized field the Company calls, “stasis and barrier applications.” Arch Therapeutics is based in Framingham, Massachusetts.

Arch’s flagship development stage product candidate is called AC5™ (AC5 Surgical Hemostatic Device™). This is a synthetic peptide consisting of naturally occurring amino acids. AC5™ is undergoing design to smoothly attain hemostasis in minimally invasive (laparoscopic) and open surgical procedures. The Company’s solution smartly controls the movement of fluids and substances. AC5™ stops bleeding quickly. AC5™ conforms to irregular wound geometry and helps in maintaining a clear field of vision directly into the wound area.

AC5™, when squirted or sprayed onto a wound, quickly intercalates into the nooks and crannies of the connective tissue where it builds itself into a physical, mechanical structure. That structure provides a barrier to leaking substances (including blood and other bodily fluids) irrespective of type of surgery or, based on early data, clotting ability, and healing occurs normally. Arch indicates that in preclinical tests, AC5™ has been simple, effective, and versatile.
 
This past February, Arch Therapeutics announced that the U.S. Patent and Trademark Office (USPTO) issued a broad method-of-use patent for products, which contain self-assembling peptidomimetics (U.S. Patent number 9,511,113). The patent is assigned to the Massachusetts Institute of Technology (MIT) and Versitech Limited and is licensed exclusively to Arch Therapeutics. The Company’s anticipation is that this patent will provide more value and opportunities for its pipeline. Arch’s 510(k) filing for external use of AC5™ will be further advanced to mid-2017 from the earlier announced target of late 2017.

Arch Therapeutics’ preclinical pipeline includes a number of product applications with high medical need. This includes care of chronic cutaneous wounds and burns, prevention of surgical adhesions, sealing gastrointestinal anastomoses and ophthalmology. Preclinical research is continuing with different partners. This approach has the advantage of managing costs and engaging relevant experts. Arch expects to advance the best product candidates further along the development cycle.

Arch Therapeutics, Inc. (ARTH), closed Friday's trading session at $0.46, up 1.06%, on 127,295 volume with 45 trades. The average volume for the last 60 days is 427,882 and the stock's 52-week low/high is $0.335/$0.945.

graphic

The QualityStocks
Company Corner

graphic
graphic

Players Network, Inc. (PNTV)

The QualityStocks Daily Newsletter would like to spotlight Players Network, Inc. (PNTV). Today, Players Network, Inc. closed trading at $0.057, up 7.55%, on 566,431 volume with 54 trades. The stock’s average daily volume over the past 60 days is 1,865,761, and its 52-week low/high is $0.0023/$0.0738.

Players Network, Inc. (PNTV) is a diversified holding company operating in marijuana and media. PNTV owns 86% of Green Leaf Farms Holdings, LLC (Green Leaf Farms) which has Nevada state-issued cultivation and production license(s). The cultivation license enables Green Leaf Farms to grow marijuana and the production license enables them to create extracts which are used for cartridges, oils and edibles. WeedTV.com is a wholly owned subsidiary which is developing the ultimate resource for the marijuana lifestyle. PNTV has been a fully reporting, publicly traded company since 1998.

Green Leaf Farms Holdings, LLC (Green Leaf)

Green Leaf produces medical and recreational cannabis products. Revenues are generated by selling their cannabis products to licensed dispensaries throughout Nevada.

Their mission is to produce the highest quality and safest pharmaceutical-grade cannabis to all levels of consumers. They utilize the most efficient cultivation methods in order to lower expenses for consumers and to maximize returns for investors.

They are a privately held company with a unique business model as they are one of only a few companies who have been granted 2 (two) Medical Marijuana Establishment (MME) licenses in Nevada; Cultivation and Production.

Their Cultivation License enables them to grow cannabis which will produce flower. Their Production License enables them to process flower (cannabis) and cannabis byproducts into extremely pure concentrates, extracts, and oils which are used in medicine, cartridges and edibles. Green Leaf has both acquired and developed proprietary cannabis strains and will continue to be committed to cannabis research and development.

Green Leaf is located in North Las Vegas, Nevada on 2.3 acres in a state-of-the-art 26,000 sq. ft. facility. They have a seasoned team of professional growers and operators to manage the facility with proven best practices to ensure they have the highest quality products available.

WeedTV.com

WeedTV.Com is a niche social network and lifestyle channel destination for the marijuana industry. They are developing the "go-to" source for information, entertainment, products and services for people who relate to the marijuana lifestyle and an active social community. WeedTV.com features daily stories sourced by WeedTV.com correspondents and contributors from around the world.

Programming includes, political news, business news on the industry, financial analysis from industry experts, growing tips, cooking tips, the "Weed101" section, medical applications/issues, lifestyle features, and entertainment specials.

WeedTV.com's first original series is titled "High Stakes." High Stakes was developed by Michael Berk, the company's Chief Creative Officer and creator of one of the most popular cable series of all time, Baywatch. High Stakes is docu-series that follows the team at Green Leaf Farms as they build their facility and launch their marijuana business.

By leveraging media, WeedTV.com builds long-term brand equity and connects consumers to businesses. This is accomplished through fresh and relevant content such as professionally produced branded television segments, user-generated videos, blogs, editorials, tweets (twitter), photos, special offers, events and custom-designed contests to engage both consumers and businesses with their brands and services.

Marijuana and Media Strategy

While developing WeedTV.com, the PNTV team realized they could implement a vertical strategy to utilize their media platform (WeedTV.com) to drive business and awareness to their cannabis products (Green Leaf Farms). Through the audience and reach of WeedTV.com, they will build brand value and cross market their own marijuana products, as well as generate revenues by marketing other companies' products and services. Disclaimer

Players Network, Inc. Company Blog

Players Network, Inc. News:

Player's Network, Inc. Launches Major Shareholder Communications Initiative

Player's Network, Inc. Announces Launch of Marijuana Accelerator Division

NetworkNewsBreaks – Player’s Network, Inc. (PNTV) Issues Update on WeedTV.com, Plans to Launch Beta

India Globalization Capital, Inc. (IGC)

The QualityStocks Daily Newsletter would like to spotlight India Globalization Capital, Inc. (NYSE: IGC). Today, India Globalization Capital, Inc. closed trading at $0.4096, up 4.52%, on 147,249 volume with 328 trades. The stock’s average daily volume over the past 60 days is 343,099, and its 52-week low/high is $0.19/$0.80.

India Globalization Capital, Inc. (IGC) is a first mover in developing a portfolio of products using cannabis-based "combination therapies" for the treatment of pain and other conditions.

The national cost of health care due to pain ranges from $560 billion to $635 billion. In addition, the health care cost attributed to the abuse of prescription opioids, closely related to pain, is approximately $25 billion. IGC's patent filing (IGC-501) is a cannabis-based formulation addressing neuropathic and arthritic pain in joints and muscles using a variety of delivery techniques. The Company anticipates commencing clinical trials, and hopes that through its focus on combination therapy it can formulate and commercialize cannabinoid compounds as an alternative to long-term addictive opioid treatments.

The Company has also filed combination therapy formulations for the treatment of epilepsy and cachexia. About 50 million people worldwide are affected by epilepsy and about 1.3 million in the U.S. experience cachexia associated with cancer, MS, Parkinson's, HIV/AIDS and other progressive illnesses. Cancer-induced anorexia/cachexia is responsible for 20% of all cancer deaths. IGC-502 indicated for seizures and IGC-504 indicated for cachexia are unique combination therapies that, if proven out by clinical trials, are expected to treat medical refractory epilepsy and eating disorders respectively, with lower side effects than conventional mono therapies.

IGC's strategy is exciting and unique in that it is aiming to become a leader in the phytocannabinoid-based combination therapy specialty pharmaceutical sector. This first mover advantage can potentially be formidable as it begins clinical trials and further builds its patent portfolio. "The development of combination therapies utilizing cannabis represents a large, unique opportunity in this emerging specialty-pharmaceutical sector. Securing FDA approval for combination therapy is believed to be significantly faster and less expensive than new drug applications. As a result, we believe that we can bring our cannabis-based pharmaceutical products to market in both an expeditious and cost-effective manner," stated Ram Mukunda, CEO.

IGC has recently exited its legacy businesses and currently holds international investments in land and in a hotel project. An impressive and experienced team, led by Mr. Ram Mukunda, CEO, directs IGC.

Mr. Mukunda holds degrees in Electrical Engineering and Mathematics from the University of Maryland (UMD). He founded and served as Chairman and CEO of Startec Global Communications, an international telecommunications carrier focused on providing voice over Internet protocol (VOIP) services to emerging economies. Startec, the first pure play international long distance carrier, went public on NASDAQ. He has won a number of awards, including the 2013 University of Maryland International Alumnus of the year award. Mr. Mukunda serves as an Emeritus member on the Board of Visitors at the University of Maryland, School of Engineering, and has served as Council Member at Harvard's Kennedy School of Government, Belfer Center of Science and International Affairs. Mr. Mukunda and Dr. Krishna are the originators of all the IGC patent filings.

Dr. Ranga Krishna, Senior Advisor, is a Board Certified Neurologist with a sub specialty in Epilepsy surgery. He is the Director of Neurology at the New York Community Hospital affiliated with New York Presbyterian Weil Cornell Medical College and the Director of Stroke Service at the New York Community Hospital affiliated with New York Presbyterian Weil Cornell Medical College. He is the Medical Director and Chairman of Total Neuro Care, P.C. He is CEO of International Pharma Trials, Inc., which assists U.S. pharmaceutical companies perform Phase II clinical trials. Dr. Krishna is a member of several organizations, including the American Academy of Neurology and the Medical Society of the State of New York. He is also a member of the Medical Arbitration panel for the New York State Workers' Compensation Board and a Founding Member of the New York State Pain Society. Dr. Krishna was trained at New York's Mount Sinai Medical Center (1991-1994) and New York University (1994-1996). Dr. Krishna and Mr. Mukunda are the originators of all the IGC patent filings. Disclaimer

India Globalization Capital, Inc. Company Blog

India Globalization Capital, Inc. News:

IGC Appoints Medical Advisor Craig Cheifetz, M.D. to Consult on the Development of Cannabis-Based, Combination Therapies

IGC Files International Patents for IGC-501 Compound Indicated for Neuropathic Pain

IGC Sells Malaysian Hotel Investment Interest, Consolidates Corporate Focus on Development of Cannabis-Based Combination Therapies

Bollente Companies, Inc. (BOLC)

The QualityStocks Daily Newsletter would like to spotlight Bollente Companies, Inc. (BOLC). Today, Bollente Companies, Inc. closed trading at $1.18, up 2.61%, on 300 volume with 1 trade. The stock’s average daily volume over the past 60 days is 4,529 and its 52-week low/high is $0.20/$1.21.

Bollente Companies, Inc. (BOLC) is in the early stages of developing a diverse portfolio of companies, targeting disruptive technologies that positively impact the environment and emerging economies. Their current focus is on high-efficiency electric tankless water heaters, manufactured and sold under "trutankless", a division of Bollente, including a line of economy tankless water heaters sold under the Vero name. Units are available for both residential and commercial application.

The primary Bollente advantage is their use of advanced technology, superior to previous tankless systems, together with a growing U.S. and global market. Traditional water heaters are one of the costliest appliances to operate. The two primary energy sources used in U.S. homes are electric and natural gas, with less than half of U.S. homes having natural gas available. In addition, there are no significant electric whole home tankless manufacturers.

The U.S. Department of Energy now requires tanks of 55 gallons or more to have efficiency levels requiring expensive heat pumps to achieve. Bollente's trutankless electric tankless water heater employs specialized sensors for constant water temperature, solid state electronics, and proprietary software, resulting in one of the most efficient heat exchangers ever produced. The technology includes smart grid and home automation capabilities, remote control and monitoring, and even smartphone alerts. It also allows adjustable custom power management settings, so that users can further enhance energy usage and performance. It is now estimated that tankless heaters used in every home would save over $8 billion annually in the U.S. alone.

By maintaining 99 percent efficiency, Bollente's trutankless heaters use less energy than tank heaters, while providing the convenience of always-hot water. The system only uses power when there is demand, producing water to exact temperature, within one degree, even with sudden changes to input. Wireless apps allow for remote settings, notifications, and monitoring, and models are compatible with existing home automation and energy management systems. The technology also reduces size, for easy location, and the system's self-flushing design provides up to 20+ years of maintenance free operation, significantly reducing upkeep and replacement costs. This becomes an additional environmental benefit since roughly 8 million used water heaters are dumped in landfills every year.

Bollente has also announced the formation of Bollente International, Inc., a wholly-owned subsidiary, for the international production and sale of trutankless systems. Taking advantage of growing interest in their technology, Bollente International is working with an international manufacturing firm for the production and distribution of trutankless systems throughout Europe, Asia, Australia and New Zealand, with the first step being the testing and certification necessary to meet the various international standards.

Bollente has made electric tankless water heating compelling to a major consumer market, both in and outside the U.S., offering economic as well as operational efficiency and convenience, attractive to builders as well as to end consumers. Disclaimer

Bollente Companies, Inc. Blog

Bollente Companies, Inc. News:

Bollente Companies Increases Presence in Trending Segment of Commercial Construction with Its Smart trutankless Product Line

Award-Winning Luxury Builder Cullum Homes Makes trutankless® the Exclusive Water Heating Solution in its Communities

Bollente Companies, Inc. (BOLC) is “One to Watch”

CD International Enterprises, Inc. (CDII)

The QualityStocks Daily Newsletter would like to spotlight CD International Enterprises, Inc. (CDII). Today, CD International Enterprises, Inc. closed trading at $0.00798, up 0.38%, on 1,140,445 volume with 28 trades. The stock’s average daily volume over the past 60 days is 2,193,327 and its 52-week low/high is $0.0001/$8.00.

CD International Enterprises, Inc. (CDII) is a U.S.-based company operating in two primary business segments: mineral trading and consulting services. Headquartered in Deerfield Beach, Florida, with operations centering on the rapid growth of the Chinese economy, CDII allows prospective investors to participate in the considerable opportunities presented by emerging markets in both the People's Republic of China and the Americas.

CDII Minerals, Inc., a wholly-owned subsidiary of CD International, serves as its commodities trading division. Through CDII Minerals, CDII sources, aggregates and distributes iron ore, manganese ore and scrap metals for clients operating throughout China. The company maintains a strategic position between its North and South American suppliers and its Chinese clients, allowing it to both address a niche market opportunity and facilitate more efficient transactions for its customers.

In addition to its mineral trading services, CDII has found success in offering a comprehensive suite of consulting services related to the unique characteristics of business operations in China. In December 2016, the company announced its entry into a two-year corporate agreement with a China-based subsidiary of Everbright International Construction Engineering Corporation, through which CDII will provide information related to foreign and domestic constructions, project tending offers, government communications and local networks. In January 2017, CDII announced its entry into a similar agreement with Zhangjiajie Shengshi Agricultural Development Company, through which it will provide consulting services related to a number of business developments, including the development of a distribution business centered on cannabidiol extract derived from industrial hemp.

Per the company's website, CDII's greatest strength lies in the quality of its personnel, which includes a culturally diverse group of professionals operating within the United States, as well as in China and emerging markets throughout the Americas. Dr. James Wang has served as CEO and chairman of the CDII board since August 2006. He has also served as CEO and chairman of China Direct Investments since January 2005. Wang brings a wealth of experience in corporate finance in the U.S. capital markets to the CDII management team, and his work in the identification and acquisition of China-based growth companies has played an instrumental role in the execution of CD International's strategic vision for over a decade.

Wang is joined on the CDII management team by Controller Shirley Xu and Vice President of Business Development Katie Zhao. Xu has served as the company's controller since January 2013, assuming a range of responsibilities including internal control, general ledger accounting oversight, and financial reporting for CDII and its subsidiaries. She is also responsible for SEC financial reporting for the company's consulting segment clients.

Katie Zhao has served in her current role with CD International since January 2012. Prior to becoming VP of business development, she served as the company's project manager from 2007 to 2009 and as senior account executive from 2010 to 2011. From these positions, Zhao played a key role in the establishment of CDII's U.S. distribution channels for its Chinese clients, as well as the implementation of a network connecting the company's U.S. and China-based offices. Disclaimer

CD International Enterprises, Inc. Blog

CD International Enterprises, Inc. News:

CD International Enterprises Enters Wholesale Distribution Agreement With Leading Global Supplier of Cannabidiol/Hemp-Derived Products

CD International Enterprises (OTC: CDII) Enters a Full Corporate Offer To Purchase Copper Cathodes Valued at Approximately $330 Million

CD International Enterprises (CDII) Signs a Letter of Intent to Purchase Iron Ore

ChineseInvestors.com (CIIX)

The QualityStocks Daily Newsletter would like to spotlight ChineseInvestors.com (CIIX). Today, ChineseInvestors.com closed trading at $0.9098, off by 5.23%, on 290,465 volume with 138 trades. The stock’s average daily volume over the past 60 days is 73,485 and its 52-week low/high is $0.12/$2.75.

Founded in 1999, ChineseInvestors.com (CIIX) has become a leading financial information website for Chinese-speaking investors in the United States and China. Recognizing unprecedented opportunities in the U.S. cannabis industry, CIIX is also laying the groundwork to capitalize on growing demand for cannabidiol (CBD)-based nutrition and health products.

Through its primary website, www.ChineseInvestors.com, CIIX offers a variety of investor education products and services, including real-time market commentary, analysis and educational related services in Chinese language character sets; consultative services to smaller private companies considering becoming a public company; and advertising and public relations related support services.

At the center of this initiative is the ChineseInvestors Method, a unique integration of a disciplined investing process, web-based tools, personalized instructions and support. Using this strategy, CIIX provides reliable market information to help investors make informed investment decisions and meet their individualized financial goals.

CIIX is also leveraging its financial expertise to enter into the burgeoning CBD industry, which within a few years has grown from a relatively invisible sector to a billowing market expected to reach $2.1 billion in consumer sales by 2020.

The increasing demand for CBD-based products is a catalyst for innovative business endeavors. To this accord, CIIX has established a three-year development plan to capitalize on the convergence of CBD and the nutrition and health products market in mainland China, where the benefits of CBD oil have not been widely recognized.

Under a wholesale agreement with a reputable CBD health brand, CIIX is launching the world's first online CBD health products store published in the Chinese language. The site, www.ChineseCBDoil.com, caters to a growing number of Chinese people awakening to the numerous health benefits of CBD oil for treatment of a variety of conditions such as anxiety, stress, poor sleep, Alzheimer's disease, and more. CIIX expects to launch this website at the end of January 2017, and plans to sell CBD-infused products via online and in-store.

In conjunction, CIIX's cannabis-focused "Yelp"-style mobile app is in development as a platform for Chinese people to review and discuss various cannabis products. The app will be the first marijuana social media mobile app designed for Chinese-speaking customers worldwide. Disclaimer

ChineseInvestors.com Blog

ChineseInvestors.com News:

ChineseInvestors.com, Inc. (CIIX) Projected To Reach Revenue of $14.8 Million by FY2020 in Consilium Global Research Report

ChineseInvestors.com, Inc. Appoints Summer Yun as CEO of CBD Biotechnology Co., Ltd., Wholly-owned Foreign Entity

Consilium Global Research Issues Executive Summary on Chinese Investors.com, Inc. (OTCQB: CIIX)

graphic

Rate Us
Tell us how we're doing!
Click here to begin your review.

Today's Top 3
Investment Newsletters

graphic

1.

Stock Beast
(VNCE) +36.38%

2.

The Street
(DYN) +25.62%

3.

NetworkNewsWire
(KOSK) +20.78%/h3>

graphic
By The Numbers Charts
QualitystockTwits

The QualityStocks Public Company Sponsor News

Featured Sponsor

Daily Sponsors
















 

The QualityStocks By The Numbers Report

Click the chart below to see the full report

About "The QualityStocks Daily"

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market
each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge"
based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?

We Want To bring our subscribers the top movers in an unbiased setting.

“Homework Eliminates Mistakes"

Please never invest in a company anyone profiles unless you do the proper research and due diligence.
QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.
Please consult the QualityStocks Market Basics Section on our site.

 

About Us     Archives     Blog     Clients     Disclaimer     Market Basics    Partners      Quotes & News     Video     Contact Us

twitter icon facebook icon

QualityStocks Logo

Copyright © 2006 - 2012. QualityStocks 3370 N. Hayden Rd., Suite 123-591, Scottsdale, AZ 85251